Elicio Therapeutics Inc.
Biotechnology
Healthcare
ELTX
16.06 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
11.21
52 week high
11.80
high
11.24
52 week low
0.00
low
11.04
growth
118.74 %
previous Close
11.14
P/E ratio
market cap
154 M
div yield
0
net incoming
-10.56 M
5.78 %
net profit margin
-1056100000.00 %
0.00 %
operating incoming
-10.09 M
6.01 %
net change in cash
3.06 M
1.00 %
cash on hand
22.09 M
20.36 %
cost of revenue
281 K
0.00 %
top